arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

TriSalus Life Sciences, Inc.

TLSI

$4.84 ▲ +0.21 (+4.54%) at close

6 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Neutral

auto_awesome

Analytical Summary

TriSalus Life Sciences, Inc. demonstrates solid fundamentals with strength in Return on Common Equity (%). Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap $183.4M

Dividend Yield —

Revenue Growth 53.4% ↘

Op. Margin -59.7% ↗

ROIC 3306.8% ↗

FCF / Share $-0.50 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity -0.98

info Valuation on last close. End-of-day price, Aug 6, 2026.

6-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$45.15M

↑ +53.4% —

Net Income Profit after all expenses

$-39.23M

↓ -30.6% —

Operating Margin Operating profit as % of sales

-59.7%

↑ +51.4% 4th

FCF / Share Free cash flow per share

$-0.50

↑ +69.3% —

Long-Term Debt Long-term obligations

$33.05M

↑ +49.6% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns

Financial Health ↑

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Revenue Growth YoY (%)	53.4% Excellent → Excellent Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+568%)	59.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+637%)	49.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+516%)	—	—	—
EPS Growth YoY (%)	-40.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	80.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	95.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—
Net Income Growth YoY (%)	-30.6% Weak ↓ Weak Declining Year-over-year change in net income	49.4% Excellent Excellent Year-over-year change in net income	-25.8% Weak Weak Year-over-year change in net income	N/M	—	—
FCF Growth YoY (%)	69.3% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	70.1% Excellent Excellent Year-over-year change in free cash flow	94.9% Excellent Excellent Year-over-year change in free cash flow	—	—	—
Revenue CAGR 3Y (%)	53.9% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Operating Margin (%) (%)	-59.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-498%)	-122.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-919%)	-294.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2062%)	-293.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2059%)	—	—
Effective Tax Rate (%) (%)	-0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-86.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-824%)	-102.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-951%)	-320.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2772%)	-380.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3272%)	—	—
FCF Margin (%) (%)	-41.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-139.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-276.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-265.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—
FCF / Net Income (x)	0.48x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.37x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.70x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-0.36x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Return on Invested Capital (%)	3306.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	949.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	201.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	20.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	18.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-76.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-150.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-221.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-165.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-1.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	115.8% Excellent → Excellent Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+672%)	116.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+674%)	219.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1362%)	26.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+78%)	-28.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-290%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Debt to Equity (x)	-0.98x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-263%)	-0.85x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-242%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	—
Interest Coverage (x)	-7.29x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-20.67x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3026.39x Weak Weak Operating income divided by interest expense Optimal: > 5x	-36439.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$12.61M	$13.56M	$-11.78M	$-9.41M	$-200.88K	$-1.33M
Debt / EBITDA (x)	-1.25x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.62x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Revenue per Share (USD)	$1.19	$1.16	$1.97	$40.04	—	—
Basic EPS, GAAP (USD)	$-1.84	$-1.31	$-6.77	$-161.55	—	—
Free Cash Flow per Share (USD)	$-0.50	$-1.63	$-5.45	$-106.48	—	—
Book Value per Share (USD)	$-0.68	$-0.83	$-1.03	$-506.80	—	—
Tangible Book Value per Share (USD)	$-0.68	$-0.83	$-1.03	$-506.80	—	—
Basic Weighted Avg Shares (shares)	37.90M	25.33M	9.40M	309,609	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Working Capital (USD)	$20.75M	$10.44M	$6.17M	$-15.14M	$-1.08M	—
LT Debt (USD)	$33.05M	$22.08M	$0.00	—	—	—
Total Equity (USD)	$-33.86M	$-25.89M	$-27.07M	$-176.33M	$-16.72M	$0.00

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Sales/Revenue/Turnover (USD)	$45.15M	$29.43M	$18.51M	$12.40M	—	—
Depreciation Expense (USD)	$600.00K	$700.00K	$700.00K	$276.00K	—	—
Net Income, GAAP (USD)	$-39.23M	$-30.05M	$-59.36M	$-47.19M	$4.77M	—
Operating Cash Flow (USD)	$-18.01M	$-40.84M	$-50.58M	$-32.31M	$-1.74M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 23 quarters

TriSalus Life Sciences, Inc.

Analytical Summary

6-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare TLSI with peers